South Korea Anesthesia Drugs Market Insight
Published: 01 June 2026 | Report Format: Electronic (PDF)
South Korea Anesthesia Drugs Market is estimated to experience a growth rate of 5.9% CAGR due to increasing surgeries, development of hospital infrastructure, and rise in demand for perioperative care therapies.
South Korea Anesthesia Drugs Market Insights Forecasts to 2035
- The South Korea Anesthesia Drugs Market Size Was Estimated USD 612.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 5.9% from 2025 to 2035
- The South Korea Anesthesia Drugs Market Size is Expected to rise around USD 1086.2 Million by 2035
Notable Insights for the South Korea Anesthesia Drugs Market
- The market share of the General Anesthesia Drugs category in the South Korea Anesthesia Drugs Market was recorded at around 58% in 2025, attributed to the rise in surgical activities, increasing complexities in procedures, and the expansion of operating rooms in hospitals.
- The Hospitals segment had an approximate market share of 64% in 2025 owing to an increasing number of surgeries carried out on an inpatient basis, critical care cases admitted, and investments in perioperative facilities.
- The anticipated global revenue of Baxter International Inc. exceeded USD 15 billion in 2025, backed by an increasing demand for injectable medicines, anesthesia equipment, and hospital services.
Download the eBook (ToC)
- Investments in perioperative monitoring using AI, infusion solutions, and advanced anesthesia management systems contribute to the growth of the market, with an increase in the effectiveness of surgery by 34% and recovery improvement by nearly 29%.
Why Buy This Report
- Provides comprehensive analysis of anesthesia drug technologies, perioperative therapeutic systems, and hospital surgical infrastructure developments influencing growth in the South Korea Anesthesia Drugs Market.
- Offers strategic insights into emerging technologies including AI-powered anesthesia monitoring platforms, precision infusion systems, smart perioperative analytics solutions, and enhanced recovery surgical care architectures.
- Supports stakeholders in evaluating competitive positioning, pharmaceutical investment strategies, surgical care developments, and advanced anesthesia therapeutics innovation trends across South Korea.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Anesthesia Drugs Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Anesthesia Drugs Market
- Baxter International Inc.
- Fresenius Kabi AG
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Viatris Inc.
- Aspen Pharmacare Holdings Limited
- B. Braun Melsungen AG
- AbbVie Inc.
- Hana Pharm Co., Ltd.
- JW Pharmaceutical Corporation
Recent Developments:
- In February 2026, Baxter International expanded injectable pharmaceutical manufacturing capabilities supporting anesthesia and perioperative care drug supply stability across global healthcare markets.
- In April 2025, Fresenius Kabi strengthened anesthesia medication portfolios and smart infusion system technologies designed to improve precision drug administration and perioperative patient safety.
Market Segmentation:
South Korea Anesthesia Drugs Market, By Drug Type
- General Anesthesia Drugs
- Local Anesthesia Drugs
- Intravenous Anesthetics
- Inhalation Anesthesia Agents
South Korea Anesthesia Drugs Market, By Technology
- AI-Based Perioperative Monitoring Systems
- Smart Infusion Technologies
- Precision Drug Delivery Platforms
- Enhanced Recovery Surgical Care Systems
South Korea Anesthesia Drugs Market, By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Emergency & Critical Care Units
Expert Views:
The South Korea anesthesia drug market will experience sustained growth in the coming years owing to the growing number of surgeries performed, increased healthcare infrastructure development, and greater adoption of perioperative technology solutions. The adoption of AI-based anesthesia monitoring systems, smart infusion systems, precision medication delivery systems, and surgical recovery technologies will enhance operational efficiency and contribute to sustained demand for these products in hospitals, ASCs, ICUs, and other perioperative healthcare environments in South Korea.
Author: Aditi and Govind By Spherical Insights and Consulting